Skip to main content
SpringerLink
Log in

Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0)

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The long-term outcomes of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer without regional and distant metastasis were retrospectively analyzed.

Methods

Patients with histologically confirmed esophageal submucosal cancers without regional and distant metastasis who received definitive concurrent chemoradiotherapy from 2001 to 2011 were included. Radiation therapy of a median total dose of 60 Gy/30 fractions (range, 54–66 Gy) with elective nodal irradiation of 40 Gy was combined concurrently with 5-furuorouracil-based chemotherapy.

Results

Thirty-six patients (33 men and 3 women) aged from 45 to 80 years (median, 67 years) were assessed. All patients had squamous cell carcinoma. With a median follow-up time of 61 months, the 5-year overall survival, disease-free survival, and locoregional failure-free survival rates were 86 % [95 % confidence interval (CI), 74–99 %], 59 % (95 % CI, 42–77 %), and 90 % (95 % CI, 79–100 %), respectively. Late toxicities of grade 3 pleural effusion in 2 patients, grade 4 pericardial effusion in 1 patient, and grade 5 pneumonitis in 1 patient were observed. Metachronous esophageal cancer was observed in 8 patients (22 %). Among them, 6 patients with mucosal legions were salvaged by endoscopic resection.

Conclusion

Our long-term results of concurrent chemoradiotherapy (CCRT) for patients with esophageal submucosal cancer showed acceptable toxicities and favorable locoregional control and survivals while maintaining organ preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hareyama M, Nishio M, Kagami Y et al (1992) Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys 24:235–240

    Article  CAS  PubMed  Google Scholar 

  2. Okawa T, Dokiya T, Nishio M et al (1999) Multi-institutional randomized trial of external radiotherapy with or without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys 45:623–628

    Article  CAS  PubMed  Google Scholar 

  3. Yorozu A, Dokiya T, Oki Y (1999) High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 45:271–275

    Article  CAS  PubMed  Google Scholar 

  4. Maingon P, Hombres A, Truc G et al (2000) High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys 46:71–76

    Article  CAS  PubMed  Google Scholar 

  5. Ishikawa H, Nonaka T, Sakurai H et al (2010) Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results. Int J Radiat Oncol Biol Phys 76:452–459

    Article  PubMed  Google Scholar 

  6. Yamada K, Murakami M, Okamoto Y et al (2006) Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal cancer. Int J Radiat Oncol Biol Phys 64:1106–1111

    Article  PubMed  Google Scholar 

  7. Kato H, Sato A, Fukuda H et al (2009) A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG9708). Jpn J Clin Oncol 39:638–643

    Article  PubMed  Google Scholar 

  8. Murakami Y, Nagata Y, Nishibuchi I et al (2012) Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol 17:263–271

    Article  PubMed  Google Scholar 

  9. Ozawa S, Tachimori Y, Baba H et al (2012) Comprehensive Registry of Esophageal Cancer in Japan, 2004. Esophagus 9:75–98

    Article  Google Scholar 

  10. Nishimaki T, Tanaka O, Suzuki T et al (1993) Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg 17:766–772

    Article  CAS  PubMed  Google Scholar 

  11. Makuuchi H, Shimada H, Mizutani K et al (1997) Clinical pathological analysis of surgically resected superficial esophageal carcinoma to determine criteria for deciding on treatment strategy. Diagn Ther Endosc 3:211–220

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Tachibana M, Yoshimura H, Kinugasa S et al (1997) Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am J Surg 174:49–53

    Article  CAS  PubMed  Google Scholar 

  13. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery (St. Louis) 123:432–439

    Article  CAS  Google Scholar 

  14. Endo M, Yoshino K, Kawano T et al (2000) Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 13:125–129

    Article  CAS  PubMed  Google Scholar 

  15. Bollschweiler E, Baldus SE, Schröder W et al (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38:149–156

    Article  CAS  PubMed  Google Scholar 

  16. Takahashi H, Arimura Y, Hosokawa M et al (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264

    Article  PubMed  Google Scholar 

  17. Altorki NK, Lee PC, Liss Y, Meherally D et al (2008) Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 247:434–439

    Article  PubMed  Google Scholar 

  18. Tachibana T, Matono S, Nagano T et al (2012) Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors. Ann Surg Oncol 19:750–756

    Article  Google Scholar 

  19. Nemoto K, Yamada S, Nishio M et al (2006) Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 26:1507–1512

    PubMed  Google Scholar 

  20. Murakami Y, Kenjo M, Uno T et al (2007) Results of the 1999–2001 Japanese Patterns of Care Study for patients receiving definitive radiation therapy without surgery for esophageal cancer. Jpn J Clin Oncol 37:493–500

    Article  PubMed  Google Scholar 

  21. Herskovic A, Martz K, Al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598

    Article  CAS  PubMed  Google Scholar 

  22. Al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284

    CAS  PubMed  Google Scholar 

  23. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) Radiation Therapy Oncology Group. JAMA 281:1623–1627

    Article  CAS  PubMed  Google Scholar 

  24. Gasper L, Winter K, Kocha W et al (2000) A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207). Cancer (Phila) 88:988–995

    Article  Google Scholar 

  25. Shimizu Y, Tukagoshi H, Fujita M et al (2001) Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resection. Gastrointest Endosc 54:190–194

    Article  CAS  PubMed  Google Scholar 

  26. Urabe Y, Hiyama T, Tanaka S et al (2009) Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection. Endoscopy 41:304–309

    Article  CAS  PubMed  Google Scholar 

  27. Adams MJ, Hardenbergh PH, Constine LS et al (2003) Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45:55–75

    Article  PubMed  Google Scholar 

  28. Ishikura S, Nihei K, Ohtsu A et al (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697–2702

    Article  CAS  PubMed  Google Scholar 

  29. Lin SH, Wang L, Myles B et al (2012) Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 84:1078–1085

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Yuji Murakami, Yoshiko Doi, Tomoyuki Okabe, Masahiro Kenjo, Tomoki Kimura & Yasushi Nagata

  2. Department of Radiation Oncology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, 1-9-6 Senda-machi, Naka-ku, Hiroshima, 730-8619, Japan

    Ippei Takahashi

  3. Department of Radiation Oncology, Hiroshima Prefectural Hospital, Ujinakanda Minami-ku, Hiroshima, 734-8530, Japan

    Ikuno Nishibuchi

Authors
  1. Yuji Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ippei Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ikuno Nishibuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshiko Doi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomoyuki Okabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masahiro Kenjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomoki Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yasushi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuji Murakami.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murakami, Y., Takahashi, I., Nishibuchi, I. et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol 20, 897–904 (2015). https://doi.org/10.1007/s10147-015-0819-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-015-0819-2

Keywords

Search

Navigation